Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Mr. Bradley L. Campbell$3B
Market Cap • 25/04/20242002
(há 22 anos)
2007
(17 years ago)
NASDAQ
Listagem
Princeton
Sede • New Jersey484
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
FOLDSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.